Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.8661
-0.0310 (-3.46%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $39.93 million as of April 25, 2025. Its market cap has decreased by -82.34% in one year.
Market Cap
39.93M
Enterprise Value
-33.98M
1-Year Change
-82.34%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $39.93M, a decrease of -90.93%. That is a compound annual growth rate of -45.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 39.93M | -39.46% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.19B |
| UnitedHealth Group | 395.96B |
| Johnson & Johnson | 374.37B |
| AbbVie | 311.52B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.24B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |